ImmuNext Competitors and Similar CompaniesClear all

ImmuNext's competitors and similar companies include Iterion Therapeutics, Coherus Oncology, JW Therapeutics and Neovii.

	ImmuNext ImmuNext is a biotech company that develops immunotherapies	Iterion Therapeutics Iterion Therapeutics is a clinical-stage biotechnology company developing targeted cancer therapeutics.	Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.	JW Therapeutics JW Therapeutics is a biotech company focusing on clinical cell therapy technology.	Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Founding Date	Founding Date 2011	Founding Date 2014	Founding Date 2010	Founding Date 2016	Founding Date 2003
Type	Type Private	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Lebanon, US HQ Alton, US	Locations Houston, US HQ	Locations Redwood City, US HQ Camarillo, US	Locations CN HQ Suzhou Shi, CN	Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US
Employees	Employees 3	Employees 17	Employees 14736% decrease	Employees 106	Employees 1193% increase
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 2.6m (almost 8 years ago)	Latest funding round N/A	Latest funding round $ 90m (about 8 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 4.4m	Total funding raised $ 174.5m	Total funding raised $ 90m	Total funding raised N/A